Baxter Healthcare Corp & Anor v Abbott Laboratories & Anor
Abbott must pay the costs thrown away by the adjournment because the late identification of possible amine impurities was due to their own failure to review disclosed documents in a timely manner, not any omission by Baxter.
- Parties
- Claimant: Baxter Healthcare Corporation; Claimant: Baxter Healthcare Limited; Defendant: Abbott Laboratories; Defendant: Central Glass Company Limited
- Jurisdiction
- England and Wales
- Judgment Date
- 02 May 2006
- Procedural Posture
- Intellectual Property Patent / Interlocutory Application (costs and Pleadings)
- Outcome
- Application for costs granted against Abbott; scope of pleading on fluorinated amines limited to Route 2 unless further particulars are provided.
- Legal Topics
- Patent Infringement, Non Infringement Declaration, Disclosure Obligations, Costs of Adjournment
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Baxter Healthcare Corporation
Claimant
Baxter Healthcare Limited
Claimant
Abbott Laboratories
Defendant
Central Glass Company Limited
Defendant
Procedural Posture
Intellectual Property Patent / Interlocutory Application (costs and Pleadings)
Legal Issues
- 1 Whether Baxter's Product and Process Description is adequate for determining non-infringement
- 2 Whether Abbott's late identification of possible amine impurities justifies further disclosure or adjournment
- 3 Who should bear the costs of adjournment due to late identification of issues
Ratio Decidendi
Abbott must pay the costs thrown away by the adjournment because the late identification of possible amine impurities was due to their own failure to review disclosed documents in a timely manner, not any omission by Baxter.
Court Disposition
Application for costs granted against Abbott; scope of pleading on fluorinated amines limited to Route 2 unless further particulars are provided.
Orders
- Abbott to pay costs thrown away by the adjournment.
- Only fluorinated amines resulting from Route 2 to be considered at trial unless Abbott explicitly raises other possibilities.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment